Nova Floresta, Brazil

Rafael Polidoro Alves Barbosa

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rafael Polidoro Alves Barbosa: Innovator in Recombinant Virus Technology

Introduction

Rafael Polidoro Alves Barbosa is a notable inventor based in Nova Floresta, Brazil. He has made significant contributions to the field of virology, particularly in the development of recombinant influenza viruses and modified Vaccinia Ankara viruses (MVA). His innovative work has the potential to advance vaccine technology and improve immunization strategies against various infections.

Latest Patents

Rafael holds 1 patent related to his research. The patent focuses on recombinant influenza viruses and modified Vaccinia Ankara viruses (MVA). It details a process for constructing these viruses with genes that encode for the parasite SAGI (MVA) and SAG2 (MVA and influenza) proteins. This is achieved through homologous recombination techniques and reverse genetics. Additionally, the invention describes a vaccine composition utilizing these recombinant viruses for immunization against infections caused by the parasite.

Career Highlights

Rafael is affiliated with the Fundação Oswaldo Cruz, a prominent research institution in Brazil. His work at this institution has allowed him to explore innovative solutions in the field of infectious diseases. His research is crucial for developing effective vaccines and therapeutic strategies.

Collaborations

Rafael has collaborated with esteemed colleagues, including Ricardo Tostes Gazzinelli and Braulia Costa Caetano. These collaborations have enriched his research and contributed to the advancement of knowledge in virology.

Conclusion

Rafael Polidoro Alves Barbosa is a pioneering inventor whose work in recombinant virus technology holds promise for future vaccine development. His contributions are vital in the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…